Type 1 Diabetes Mellitus: Autoimmune Mechanisms and Treatment

Abstract

This article provides a comprehensive overview of Type 1 Diabetes Mellitus (T1DM), highlighting the autoimmune origins of the illness and its therapeutic options. It discusses the role of insulin in metabolism and highlights the fact that the autoimmune destruction of pancreatic beta cells is the primary characteristic of type 1 diabetes. Environmental triggers such as viral infections, cow's milk proteins, and insufficient vitamin D are studied in addition to genetic factors such as specific alleles associated with the disease's susceptibility. The report discusses the global epidemiology of T1DM and its increasing incidence, emphasizing the need for a comprehensive approach to treatment. Various treatment options are evaluated, emphasizing the need for customized approaches to treat this complex autoimmune disease. These options include gene therapy, insulin treatment, immunomodulatory medications, and vaccination. All things considered, the study adds to our understanding of T1DM and highlights the ongoing need to develop effective treatment modalities.